Collagen Matrix, Inc.

What Collagen Matrix, Inc. does

Collagen Matrix, Inc., operating commercially as Regenity Biosciences, is a US-based medical device company founded in 1997 that develops and manufactures bioresorbable regenerative devices for tissue repair and regeneration. Its technology is anchored in two proprietary platforms: a xenograft-based collagen platform (the original foundation of the company) and a synthetic polymer bioresorbable platform acquired through the 2022 purchase of Polyganics. These platforms underpin a portfolio spanning dental membranes and bone graft substitutes, dural repair and closure devices, spine and orthopedic regenerative implants (including the 2024 FDA 510(k)-cleared RejuvaKnee meniscus implant), nerve repair devices, and neurosurgical products such as the GammaTile brain tumor treatment co-developed with GT Medical Technologies. The company holds ISO 13485 and MDSAP certifications, is FDA-registered, and reports 170+ regulatory approvals worldwide with 5M+ devices produced annually and products reaching 80+ countries.

Regenity operates a hybrid business model combining private-label/OEM supply with full-service CDMO (Contract Development and Manufacturing Organization) capabilities, providing collaborative product development from design through precision manufacturing for medical device partners ranging from startups to large healthcare companies. Revenue is generated through one-time private-label product sales and professional services for customized development projects, with pricing not publicly disclosed. The company serves four primary end-user segments — dental healthcare providers, spine and orthopedic surgeons, neurosurgery practitioners, and wound care providers — plus medical device companies using its CDMO services, giving it a horizontal segmentation across therapeutic use cases.

The company is headquartered in Paramus, New Jersey, with a new Allendale, NJ campus announced in April 2026 to support capacity growth. It is privately held under a dual-sponsor structure: Linden Capital Partners as legacy investor and Cinven as a new strategic investor following a February 2026 capital commitment. Recent milestones include FDA 510(k) clearance for RejuvaKnee, NMPA approval in China for its collagen dental membrane, and recognition with the 2025 R&D 100 Award, collectively indicating an active expansion phase across products, geographies, and capacity.

Name

Collagen Matrix, Inc.

Legal name

Collagen Matrix, Inc.

Website

https://collagenmatrix.com

Company type

Private

Founded year

1997

Operating status

Operating

Headcount range

101–250 employees

Short description

Regenity Biosciences (formerly Collagen Matrix, Inc.) is a US medical device company that develops and manufactures bioresorbable regenerative devices for dental, spine/orthopedic, neurosurgical, and wound-care applications, and offers CDMO services to medical device partners globally.

Ownership category

akta.pro rank

Product category

Regenerative Medical Devices

NAICS

Medical Equipment and Supplies Manufacturing (3391), Surgical and Medical Instrument Manufacturing (339112)

SIC

Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842), Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Clinical Trial Material (CTM) Manufacturing & Supply CDMO (HLAGABAK)

Keywords

• Bioresorbable medical devices
• Regenerative medicine implants
• Collagen scaffold products
• Medical device CDMO
• Tissue repair devices

Headquarters

HQ city

Oakland

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Operations, Personnel, Technology or R&D, Supply Chain, Infrastructure, Marketing or Sales

Revenue model

1. Private-label Products: Regenity manufactures and supplies private-label bioresorbable medical devices to partners in the regenerative medicine space
2. CDMO Services: Contract Development and Manufacturing Organization services including collaborative product development from design to precision manufacturing, supporting partners in bringing regenerative therapies to market
3. Customized Product Development: Fully customized, collaborative product development leveraging proprietary technology platforms and design asset library

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

Core offering

Regenity Biosciences (formerly Collagen Matrix, Inc.) designs, manufactures, and supplies bioresorbable medical devices for tissue repair and regeneration across dental, dural repair, spine/orthopedic, and nerve repair applications, built on proprietary collagen and synthetic polymer platforms. In addition to its own branded product portfolio (including RejuvaKnee meniscus implant and collagen dental membranes), the company operates as a Contract Development and Manufacturing Organization (CDMO), providing private-label products and fully customized collaborative product development for medical device partners globally.

Product overview

Regenity Biosciences (formerly Collagen Matrix, Inc.) operates as a regenerative medicine company offering a unified platform of bioresorbable medical devices complemented by contract manufacturing services. The product portfolio centers on proprietary collagen and synthetic polymer technology platforms that serve therapeutic areas including Dental, Dural Repair & Closure, Spine & Orthopedics, and Nerve Repair. Key products include RejuvaKnee (regenerative meniscus implant), Collagen Dental Membrane, and GammaTile (brain tumor treatment). The company provides private-label products alongside fully customized collaborative product development, supported by CDMO services for design, development, and scalable manufacturing.

Differentiator

Problem solved

Functional benefit

Brands

• RejuvaKnee: Groundbreaking regenerative meniscus implant device that received 510(k) clearance from FDA and won the 2025 R&D 100 Award

Products and services

• RejuvaKnee Regenerative meniscus implant device for meniscal repair that provides a bioresorbable scaffold enabling natural tissue restoration, intended to redefine the standard of care for orthopedic surgeons and sports medicine physicians.
• Collagen Dental Membrane Crosslinked collagen membrane for dental applications including guided tissue regeneration and bone grafting procedures, for dental surgeons and oral healthcare providers.
• Dural Repair and Closure Devices Bioresorbable devices for dural repair and surgical closure in neurological and ENT procedures, designed for neurosurgeons.
• Spine and Orthopedic Regenerative Devices Regenerative solutions for spine and orthopedic applications including bone void fillers and regenerative implants for spinal fusion, orthopedic surgery, and sports medicine.
• Nerve Repair Devices Bioresorbable devices designed for nerve repair and regeneration applications.
• CDMO Services Contract Development and Manufacturing Organization services supporting medical device partners from design through precision manufacturing of regenerative medical devices, including private-label products and fully customized collaborative product development.

Quantifiable outcome

• 30M+ patients' lives impacted
• +3 more outcomes

Named customers2 records

Segments5 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Two partnerships are on record, tiered core and strategic.

• PolyganicscoreOEM/ Whitelabel/ Licensing Partner · 5 October 2022Collagen Matrix acquired Polyganics, a medical technology company specializing in bioresorbable medical devices. The acquisition added Polyganics' polymer platform to Collagen Matrix's product range, enabling entry into new surgical markets and enhancing R&D capabilities.
• GT Medical TechnologiesstrategicStrategic or Co-development PartnerGT Medical Technologies partnered with Regenity for the development and manufacturing of GammaTile - a breakthrough brain tumor treatment device. Regenity's deep expertise and regulatory know-how enabled successful product development.

Scale indicators7 records

Recent moves8 records

Expansion highlights5 records

Broad incumbents

• Smith+Nephew: Major incumbent in orthopedic medical devices, sports medicine, and advanced wound care. Competes with Regenity in regenerative orthopedic and wound healing segments as part of a broader diversified portfolio.
• Stryker: Global medical device incumbent with significant orthopedic, spine, and surgical product lines. Competes in bone void fillers, sports medicine, and surgical regenerative applications as part of a broad medtech portfolio.
• Medtronic: Largest medical device incumbent with significant spine, neurosurgery, and regenerative medicine exposure. Overlaps with Regenity in dural repair, spine biologics, and surgical regenerative device categories.
• Baxter International: Diversified medical products incumbent with surgical solutions and regenerative medicine exposure. Competes in surgical hemostats, sealants, and tissue repair categories where Regenity operates.

Direct peers

• Organogenesis: Direct peer in regenerative medicine, specializing in biologics and tissue-based products for wound care and surgical applications. Comparable in offering collagen- and biologically-derived medical devices to healthcare providers.
• Integra LifeSciences: Direct peer in regenerative medicine and surgical medical devices, particularly strong overlap in dural repair, regenerative matrices, and orthopedic soft tissue repair. Competes head-to-head in neurosurgery and spine/orthopedic applications.
• Geistlich Pharma: Direct peer in dental regenerative medicine, with its Bio-Gide collagen membrane explicitly named as a comparator in Regenity's China clinical study. Closest direct competitor in dental collagen membranes and bone regeneration.
• MiMedx: Direct peer in regenerative medicine, specializing in placental tissue allografts for wound care, surgical, and orthopedic applications. Comparable focus on biologically-derived regenerative medical devices.
• Anika Therapeutics: Direct peer focused on regenerative medicine for orthopedics, including hyaluronic acid-based and bioresorbable products. Overlaps with Regenity in cartilage/meniscus repair and orthopedic regenerative applications.

Emerging players

• LifeNet Health: Nonprofit tissue allograft provider focused on regenerative medicine for orthopedics, spine, and wound care. Comparable in offering tissue-based regenerative medical devices, though as a non-profit model with different commercial dynamics.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/@regenity
• LinkedInlinkedin.com/company/collagen-matrix-inc-
• Xx.com/collagenmatrix
• Facebookfacebook.com/collagenmatrixinc

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A2 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Collagen Matrix, Inc.